Resveratrol ameliorates DNA damage, prooxidant and antioxidant imbalance in 1,2-dimethylhydrazine induced rat colon carcinogenesis

Chemico-Biological Interactions

Volumn 181, Issue 2, 2009, Pages 193-201

  Sengottuvelan, M ^a   Deeptha, K ^a   Nalini, N ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

1,2 Dimethylhydrazine; Antioxidants; Colorectal cancer; Comet assay; Lipid peroxidation; Resveratrol

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; RESVERATROL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE LEVEL; GENOTOXICITY; LEUKOCYTE COUNT; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; VITAMIN BLOOD LEVEL;

1,2-DIMETHYLHYDRAZINE; ANIMALS; ANTIOXIDANTS; CARCINOGENS; COLONIC NEOPLASMS; COMET ASSAY; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPID PEROXIDATION; MALE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; STILBENES;

RATTUS;

EID: 68849096024     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.06.004     Document Type: Article

References (63)

1. Soleas G.J., Diamandis E.P., and Goldberg D.M. Resveratrol: a molecule whose time has come? And gone?. Clin. Biochem. 30 (1997) 91-113
2. King R., Bomser J., and Min D. Bioactivity of resveratrol. Compr. Rev. Food Sci. Food Safety 5 (2006) 65-70
3. Vingtdeux V., Dreses-Werringloer U., Zhao H., Davies P., and Marambaud P. Therapeutic potential of resveratrol in Alzheimer's disease. BMC Neurosci. 9 Suppl. 2 (2008) S6
4. Das S., and Das D.K. Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Pat. Cardiovasc. Drug Discov. 2 (2007) 133-138
5. Gruber J., Tang S.Y., and Halliwell B. Evidence for a trade-off between survival and fitness caused by resveratrol treatment of Caenorhabditis elegans. Ann. N.Y. Acad. Sci. 1100 (2007) 530-542
6. Baxter R.A. Anti-aging properties of resveratrol: review and report of a potent new antioxidant skin care formulation. J. Cosmet. Dermatol. 7 (2008) 2-7
7. Fabris S., Momo F., Ravagnan G., and Stevanato R. Antioxidant properties of resveratrol and piceid on lipid peroxidation in micelles and monolamellar liposomes. Biophys. Chem. 135 (2008) 76-83
8. Fauconneau B., Waffo-Teguo P., Huguet F., Barrier L., Decendit A., and Merillon J.M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci. 61 (1997) 2103-2110
9. de la Lastra C.A., and Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol. Nutr. Food Res. 49 (2005) 405-430
10. Billack B., Radkar V., and Adiabouah C. In vitro evaluation of the cytotoxic and anti-proliferative properties of resveratrol and several of its analogs. Cell Mol. Biol. Lett. 13 (2008) 553-569
11. Uenobe F., Nakamura S., and Miyazawa M. Antimutagenic effect of resveratrol against Trp-P-1. Mutat. Res. 373 (1997) 197-200
12. Wen X., and Walle T. Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis 26 (2005) 1774-1781
13. Damianaki A., Bakogeorgou E., Kampa M., Notas G., Hatzoglou A., Panagiotou S., Gemetzi C., Kouroumalis E., Martin P.M., and Castanas E. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J. Cell. Biochem. 78 (2000) 429-441
14. Kampa M., Hatzoglou A., Notas G., Damianaki A., Bakogeorgou E., Gemetzi C., Kouroumalis E., Martin P.M., and Castanas E. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr. Cancer 37 (2000) 223-233
15. Asou H., Koshizuka K., Kyo T., Takata N., Kamada N., and Koeffier H.P. Resveratrol a natural product derived from grapes, is a new inducer of differentiation in human myeloid leukemias. Int. J. Hematol. 75 (2002) 528-533
16. van Ginkel P.R., Sareen D., Subramanian L., Walker Q., Darjatmoko S.R., Lindstrom M.J., Kulkarni A., Albert D.M., and Polans A.S. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin. Cancer Res. 13 (2007) 5162-5169
17. Bishayee A., and Dhir N. Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. Chem. Biol. Interact. 179 (2009) 131-144
18. Wang T.T., Hudson T.S., Wang T.C., Remsberg C.M., Davies N.M., Takahashi Y., Kim Y.S., Seifried H., Vinyard B.T., Perkins S.N., and Hursting S.D. Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis 29 (2008) 2001-2010
19. Weisburger J.H., Reddy B.S., and Wynder E.L. Colon cancer: its epidemiology and experimental production. Cancer 40 (1977) 2414-2420
20. Fiala E.S. Investigations into the metabolism and mode of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane. Cancer 40 (1977) 2436-2445
21. Rogers K.J., and Pegg A.E. Formation of O6-methylguanine by alkylation of rat liver, colon, and kidney DNA following administration of 1,2-dimethylhydrazine. Cancer Res. 37 (1977) 4082-4087
22. Newell L.E., and Heddle J.A. The potent colon carcinogen, 1,2-dimethylhydrazine induces mutations primarily in the colon. Mutat. Res. 564 (2004) 1-7
23. Kinjo T., Suzui M., Morioka T., Nabandith V., Inamine M., Kaneshiro T., Arakaki J., Nishimaki T., and Yoshimi N. Distribution of preneoplastic lesions and tumors, and beta-catenin gene mutations in colon carcinomas induced by 1,2-dimethylhydrazine plus dextran sulfate sodium. J. Exp. Clin. Cancer Res. 25 (2006) 89-95
24. Arutiunian A.V., Prokopenko V.M., Burmistrov S.O., Oparina T.I., Frolova E.V., Zabezhinskiǐ M.A., Popovich I.G., and Anisimov V.N. Free-radical processes in blood serum, liver and large bowel during 1,2-dimethylhydrazine-induced carcinogenesis in rats. Vopr. Onkol. 43 (1997) 618-622
25. Cerutti P.A. Oxy-radicals and cancer. Lancet 344 (1994) 862-863
26. Glass G.A., and Gershon D. Decreased enzymic protection and increased sensitivity to oxidative damage in erythrocytes as a function of cell and donor aging. Biochem. J. 218 (1984) 531-537
27. Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic. Biol. Med. 8 (1990) 583-599
28. Fang Y.Z., Yang S., and Wu G. Free radicals, antioxidants, and nutrition. Nutrition 18 (2002) 872-879
29. Frei B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am. J. Med. 97 (1994) 5-13
30. Gordon M. Dietary antioxidants in disease prevention. Nat. Prod. Rep. 13 (1996) 265-273
31. Sengottuvelan M., Viswanathan P., and Nalini N. Chemopreventive effect of trans-resveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis 27 (2006) 1038-1046
32. Rice-Evans C., and Miller N.J. Total antioxidant status in plasma and body fluids. Methods Enzymol. 234 (1994) 279-293
33. Singh N.P., McCoy M.T., Tice R.R., and Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175 (1988) 184-191
34. Dodge J.T., Mitchell C., and Hanahan D.J. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch. Biochem. Biophys. 100 (1963) 119-129
35. Drabkin D.L., and Austin J.H. Spectrophotometric studies. I. Spectrophotometric constants for common hemoglobin derivatives in human, dog, and rabbit blood. J. Biol. Chem. 98 (1932) 719-733
36. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
37. Recknagel R.O., and Glende Jr. E.A. Spectrophotometric detection of lipid conjugated dienes. Methods Enzymol. 105 (1984) 331-337
38. Jiang Z.Y., Hunt J.V., and Wolff S.P. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal. Biochem. 202 (1992) 384-389
39. Kakkar P., Das B., and Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys. 21 (1984) 130-132
40. Sinha A.K. Colorimetric assay of catalase. Anal. Biochem. 47 (1972) 389-394
41. Flohe L., and Gunzler W.A. Assays of glutathione peroxidase. Methods Enzymol. 105 (1984) 114-121
42. Habig W.H., and Jakoby W.B. Glutathione S-transferases (rat and human). Methods Enzymol. 77 (1981) 218-231
43. Carlberg I., and Mannervik B. Glutathione reductase. Methods Enzymol. 113 (1985) 484-490
44. Boyne A.F., and Ellman G.L. A methodology for analysis of tissue sulfhydryl components. Anal. Biochem. 46 (1972) 639-653
45. Desai I.D. Vitamin E analysis methods for animal tissues. Methods Enzymol. 105 (1984) 138-147
46. Omaye S.T., Turnbull J.D., and Sauberlich H.E. Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol. 62 (1979) 3-11
47. Bayfield R.F., and Cole E.R. Colorimetric estimation of vitamin A with trichloroacetic acid. Methods Enzymol. 67 (1980) 189-195
48. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., and Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
49. Boxenbaum H., and DiLea C. First-time-in-human dose selection: allometric thoughts and perspectives. J. Clin. Pharmacol. 35 (1995) 957-966
50. Pervaiz S. Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol. Drug Resist. Updat. 7 (2004) 333-344
51. Wood A.W., Huang M.T., Chang R.L., Newmark H.L., Lehr R.E., Yagi H., Sayer J.M., Jerina D.M., and Conney A.H. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 5513-5517
52. Stoner G.D., Morse M.A., and Kelloff G.J. Perspectives in cancer chemoprevention. Environ. Health Perspect. 105 (1997) 945-954
53. Nordberg J., and Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31 (2001) 1287-1312
54. Kinnula V.L., and Crapo J.D. Superoxide dismutases in malignant cells and human tumors. Free Radic. Biol. Med. 36 (2004) 718-744
55. Kawanishi S., and Yamamoto K. Mechanism of site-specific DNA damage induced by methylhydrazines in the presence of copper(II) or manganese(III). Biochemistry 30 (1991) 3069-3075
56. Manju V., and Nalini N. Chemopreventive efficacy of ginger, a naturally occurring anticarcinogen during the initiation, post-initiation stages of 1,2-dimethylhydrazine-induced colon cancer. Clin. Chim. Acta. 358 (2005) 60-67
57. De Rosa M.C., Carelli Alinovi C., Galtieri A., Scatena R., and Giardina B. The plasma membrane of erythrocytes plays a fundamental role in the maintenance of the reduced state of the heme iron. Gene 398 (2007) 162-171
58. Murias M., Jager W., Handler N., Erker T., Horvath Z., Szekeres T., Nohl H., and Gille L. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem. Pharmacol. 69 (2004) 903-912
59. Navarro J., Obrador E., Carretero J., Petschen I., Avino J., Perez P., and Estrela J.M. Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo. Free Radic. Biol. Med. 26 (1999) 410-418
60. Chang T.K., Chen J., and Lee W.B. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. J. Pharmacol. Exp. Ther. 299 (2001) 874-882
61. Das U. A radical approach to cancer. Med. Sci. Monit. 8 (2002) 79-92
62. Wefers H., and Sies H. The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E. Eur. J. Biochem. 174 (1988) 353-357
63. Imaida K., Hirose M., Yamaguchi S., Takahashi S., and Ito N. Effects of naturally occurring antioxidants on combined 1,2-dimethylhydrazine- and 1-methyl-1-nitrosourea-initiated carcinogenesis in F344 male rats. Cancer Lett. 55 (1990) 53-59